SLSarah L. Logan

Sarah L. Logan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah L. Logan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders

    by Sarah L. Logan, Laura Carpenter, R. Scott Leslie, Elizabeth Garrett-Mayer, Kelly J. Hunt, Jane Charles, Joyce S. Nicholas

    The purpose of this study was to identify rates and predictors of psychotropic medication polypharmacy among Medicaid-eligible children in South Carolina with autism spectrum disorder (ASD) from 2000 to 2008. Population-based surveillance data were linked with state Medicaid records to obtain a detailed demographic, behavioral, educational, clinical, and diagnostic data set for all Medicaid-eligible 8-year-old children (n=629) who were identified and diagnosed with ASD using standardized criteria. Polypharmacy was defined as having interclass psychotropic medication claims overlapping for ≥30 consecutive days at any time during the 2-year study period. Multivariable logistic regression was used to model predictors of any polypharmacy, and for the three most common combinations. Overall, 60% (n=377) used any psychotropic medication, and 41% (n=153) of those had interclass polypharmacy. Common combinations were attention-deficit/hyperactivity disorder (ADHD) medications with an antidepressant (A/AD), antipsychotic (A/AP) or a mood stabilizer (A/MS). Black children had lower odds of any polypharmacy, as did those eligible for Medicaid because of income or being foster care versus those eligible because of disability. There were no significant associations between polypharmacy and social deficits in ASD for any combination, although children with communication deficits diagnostic of ASD had lower odds of any polypharmacy and A/AP polypharmacy. Children with argumentative, aggressive, hyperactive/impulsive, or self-injurious aberrant behaviors had higher odds of polypharmacy, as did children with diagnosed co-occurring ADHD, anxiety or mood disorders, or conduct/oppositional defiant disorder (ODD) in Medicaid records. Future research is warranted to investigate how child-level factors impact combination psychotropic medication prescribing practices and outcomes in ASD.


  • Open Access

    Imaging the neural mechanisms of TMS neglect-like bias in healthy volunteers with the interleaved TMS/fMRI technique: preliminary evidence

    by Raffaella Ricci, Adriana Salatino, Xingbao Li, Agnes P. Funk, Sarah L. Logan, Qiwen Mu, Kevin A. Johnson, Daryl E. Bohning, Mark S. George

    Applying a precisely timed pulse of transcranial magnetic stimulation (TMS) over the right posterior parietal cortex (PPC) can produce temporary visuo-spatial neglect-like effects. Although the TMS is applied over PPC, it is not clear what other brain regions are involved. We applied TMS within a functional magnetic resonance imaging (fMRI) scanner to investigate brain activity during TMS induction of neglect-like bias in three healthy volunteers, while they performed a line bisection judgment task (i.e., the landmark task). Single-pulse TMS at 115% of motor threshold was applied 150 ms after the visual stimulus onset. Participants completed two different TMS/fMRI sessions while performing this task: one session while single-pulse TMS was intermittently and time-locked applied to the right PPC and a control session with TMS positioned over the vertex. Perceptual rightward bias was observed when TMS was delivered over the right PPC. During neglect-like behavior, the fMRI maps showed decreased neural activity within parieto-frontal areas, which are often lesioned or dysfunctional in patients with left neglect. Vertex TMS induced behavioral effects compatible with leftward response bias and increased BOLD signal in the left caudate (a site which has been linked to response bias). These results are discussed in relation to recent findings on neural networks subserving attention in space.


  • Postpartum Screening Following GDM: How Well Are We Doing?

    by Kelly J. Hunt, Sarah L. Logan, Deborah L. Conway, Jeffrey E. Korte

    Once diagnosed with gestational diabetes mellitus (GDM), a woman has a sevenfold increased risk of developing type 2 diabetes relative to women who do not have diabetes during pregnancy. In addition, up to one third of women with GDM have overt diabetes, impaired fasting glucose, or impaired glucose tolerance identified during postpartum glucose screening completed within 6 to 12 weeks. Therefore, the American Diabetes Association, the World Health Organization, and the American College of Obstetricians and Gynecologists currently recommend postpartum glucose screening following GDM. However, despite this recommendation, in many settings the majority of women with GDM fail to return for postpartum glucose testing. Studies conducted to date have not comprehensively examined the health care system, the physician, or the patient determinants of successful screening. These studies are required to help develop standard clinical procedures that enable and encourage all women to return for postpartum glucose screening following GDM.